| Application no. and date | 17204116.2 (espacenet) (Federated) (European Patent Register), 20150619 | | Patent/reg. no. and date | DK/EP 3321270, 20241204 | | Publication date | 20180516 | | Priority no. and date | US 201462015245 P, 20140620 | | EP pub. no. and date |
EP 3321270 20180516 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US | | Applicant ref. no. | | | Inventor | CHEN, Irene, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404, US,
ZIA, Vahid, c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404, US,
CARRA, Ernest A., c/o Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404, US | | Representative | | | Opponent | | | IPC Class | A61K 31/513 (2006.01) , A61K 31/553 (2006.01) , A61K 31/675 (2006.01) , A61K 31/683 (2006.01) , A61K 45/06 (2006.01) , A61K 9/20 (2006.01) , A61P 31/00 (2006.01) , A61P 31/18 (2006.01) , A61P 43/00 (2006.01) , C07D 498/14 (2006.01) , C07D 498/18 (2006.01) | | Title | SODIUM (2R, 5S, 13AR) -7, 9-DIOXO-10- ( (2,4,6-TRIFLUOROBENZYL) CARBAMOYL) -2, 3, 4, 5, 7, 9, 13, 13A-OCTAHYDRO-2, 5-METHANOPYRIDO [1',2' : 4.5] PYRAZINO [2, 1-B] OXAZEPIN-8-OLATE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
